Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
A group of 90 patients suffering from chronic cerebrovascular disease (CCVD) were selected on the basis of definite clinical criteria and pretests indicating a well-preserved general level of the higher functions. The purpose was to perform a clinical and neuropsychological assessment of CCVD sufferers during treatment with vincamine teprosilate (Teproside) for 90 days. Each selected patient was submitted to neurological examination and neuropsychological testing before treatment, after 45 days and at the termination of treatment. Neuropsychological examination included the reaction-time task, memory tests, verbal fluency test, trail making test, PM 38, MACL and STAI depression scales. Preliminary results are discussed and compared with previous data reported in the literature.
D000368:Aged; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D011897:Random Allocation; D014748:Vinca Alkaloids / Q000627:therapeutic use*; D014749:Vincamine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*
D014748:Vinca Alkaloids; C038060:vincamine teproside; D014749:Vincamine